BPA CALL
Active75F40126F19009
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$1.4M
obligated · signed 1 month ago
EO 14398-FIRM-FIXED-PRICE BPA CALL UNDER BPA 75F40122A00018 TO PROVIDE RESEARCH, ANALYTICAL, LABELING STRATEGY, STAKEHOLDER ENGAGEMENT, PROJECT MANAGEMENT, AND RELATED SUPPORT SERVICES FOR FDA CDER'S DRUG LABELING INITIATIVE AND DRUG REPURPOSING
Performance timeline
Start
Aug 21, 2026
Potential end
Sep 29, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Sep 29, 2027
DELOITTE CONSULTING LLP
Contract 75F40126F19009
UEI
CKV2L9GZKJK3
Parent Company
DELOITTE CONSULTING LLP
Capabilities & Certifications
Headquarters Location
Congressional District: 08
Current Obligation
$1,426,532
Base + Exercised Options
$1,426,532
Total Ceiling Value
$1,426,532
Contract Type
FIRM FIXED PRICE
NAICS
ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES
PSC
SPECIAL STUDIES/ANALYSIS- REGULATORY
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Contract Vehicle
75F40122A00018
BPADepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.